Title: Icare Finland Makes Tonometry Possible During Coronavirus Time Author(s): Andrew Sweeney Publisher: Cake Magazine Type: Trade Publication Release Date: May 5, 2020 Summary:
(…) Icare Finland Oy believes its Icare HOME Tonometer system is the solution ophthalmologists need in the coronavirus era. The device is small enough to fit in one’s hand, allows for 24-hour monitoring, and can be used at home as easily as in the clinic. It’s also based on a rebound measuring principle that requires no drops or specialized skills for its use, thus eliminating the risk of transmission via air particles. (…)
Title: Single Use Icare Probes Recommended to Measure IOP During COVID Crisis Author(s): MINEWS Publisher: MiVision Ophthalmic Journal Type: Trade Publication Release Date: April 14, 2020 Summary:
RANZCO has cautioned that puff tonometry should not be used, and disposable probes are preferred when measuring the intraocular pressures of patients with, or suspected of having, glaucoma.
Title: Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong Author(s): Tracy H. T. Lai, Emily W. H. Tang, Sandy K. Y. Chau, Kitty S. C. Fung, Kenneth K. W. Li Publisher: Graefe's Archive for Clinical and Experimental Ophthalmology Type: Trade Journal - Peer Reviewed Release Date: March 3, 2020 Summary:
Coronavirus disease (COVID-19) has rapidly emerged as a global health threat. The purpose of this article is to share our local experience of stepping up infection control measures in ophthalmology to minimize COVID-19 infection of both healthcare workers and patients.
Infection control measures implemented in our ophthalmology clinic are discussed. The measures are based on detailed risk assessment by both local ophthalmologists and infection control experts.
A three-level hierarchy of control measures was adopted. First, for administrative control, in order to lower patient attendance, text messages with an inquiry phone number were sent to patients to reschedule appointments or arrange drug refill. In order to minimize cross-infection of COVID-19, a triage system was set up to identify patients with fever, respiratory symptoms, acute conjunctivitis or recent travel to outbreak areas and to encourage these individuals to postpone their appointments for at least 14 days. Micro-aerosol generating procedures, such as non-contact tonometry and operations under general anesthesia were avoided. Nasal endoscopy was avoided as it may provoke sneezing and cause generation of droplets. All elective clinical services were suspended. Infection control training was provided to all clinical staff. Second, for environmental control, to reduce droplet transmission of COVID-19, installation of protective shields on slit lamps, frequent disinfection of equipment, and provision of eye protection to staff were implemented. All staff were advised to measure their own body temperatures before work and promptly report any symptoms of upper respiratory tract infection, vomiting or diarrhea. Third, universal masking, hand hygiene, and appropriate use of personal protective equipment (PPE) were promoted.
We hope our initial experience in stepping up infection control measures for COVID-19 infection in ophthalmology can help ophthalmologists globally to prepare for the potential community outbreak or pandemic. In order to minimize transmission of COVID-19, ophthalmologists should work closely with local infection control teams to implement infection control measures that are appropriate for their own clinical settings.